Cargando…
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
Incomplete O-glycosylation is a feature associated with malignancy resulting in the expression of truncated glycans such as the sialyl-Tn (STn) antigen. Despite all the progress in the development of potential anti-cancer antibodies, their application is frequently hindered by low specificities and...
Autores principales: | Loureiro, Liliana R., Sousa, Diana P., Ferreira, Dylan, Chai, Wengang, Lima, Luís, Pereira, Carina, Lopes, Carla B., Correia, Viviana G., Silva, Lisete M., Li, Chunxia, Santos, Lúcio Lara, Ferreira, José Alexandre, Barbas, Ana, Palma, Angelina S., Novo, Carlos, Videira, Paula A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093877/ https://www.ncbi.nlm.nih.gov/pubmed/30111774 http://dx.doi.org/10.1038/s41598-018-30421-w |
Ejemplares similares
-
Challenges in Antibody Development against Tn and Sialyl-Tn Antigens
por: Loureiro, Liliana R., et al.
Publicado: (2015) -
Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression
por: Murugesan, Gavuthami, et al.
Publicado: (2020) -
Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
por: Loureiro, L. R., et al.
Publicado: (2018) -
Sialyl-Tn in Cancer: (How) Did We Miss the Target?
por: Julien, Sylvain, et al.
Publicado: (2012) -
Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
por: Lima, L, et al.
Publicado: (2013)